© 2022 Vial. All rights reserved
The CRO Built for Sponsors
Run your trial with faster execution and higher quality. The Vial CRO leverages our Clinic Network of over 35 Clinics and CRO capabilities to provide our sponsors with faster, higher quality trial outcomes.
35+
Clinical Research Sites
750+
Trials Completed
6
Therapeutic Areas
Vial's vision
is to empower scientists
to cure all human disease.
Vial's mission is to run clinical trials
with faster execution and higher quality
in order to bring new therapies to market.
We found our calling in clinical trials after learning the pain points directly. It is curiosity that propels us to keep building, finding new challenges, and fulfilling our vision of reimagining clinical trials.
Meet our Leadership Team
Our team merges an expertise in technology and CRO operations. We have built $1B+ technology products and have over 25 years experience managing best in class research sites.
Simon Burns
Co-founder & Chief Executive Officer
Andrew Brackin
Co-founder & Chief Revenue Officer
Betsey Zbyszynski
VP, Head of Dermatology
Marcia Swank
VP, Head of Ophthalmology
Janet DuBois, MD
Medical Director
Justin Withers
Head of Dermatology (Site Network)
Danielle McNulty
Director of Project Management
Tina Jiang
GM - Patients Experience
Will MacInnis
VP Finance
Ananya Shah
Head of Business Operations
Carly Warner
Head of People
Scientific Advisory Board
Vial CRO is supported by a team of Scientific Advisors who review and provide input on the strategy and direction of the CRO in order to build the infrastructure to advance research.
Dr. Guru Sonpavde
Bladder Cancer Director at the Dana-Farber Cancer Institute and Associate Professor of Medicine at Harvard Medical School
Dr. Neeraj Agarwal
Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah
Dr. Arshad Khanani
Managing Partner, Director of Clinical Research, and Director of Fellowship at Sierra Eye Associates
Dr. Mark Lebwohl
Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of and Chairman of the Department of Dermatology at the Mount Sinai Hospital in New York City
Dr. Luke Nordquist
CEO at Urology Cancer Center and XCancer Research
Dr. Arvind Chaudhry
Director of Summit Cancer Centers, Medical Oncologist
Dr. Nancy Holekamp
Director of Retina Services at the Pepose Vision Institute
Dr. David Pariser
Senior physician of Pariser Dermatology Specialist and Principal Investigator
Dr. Arati Rao
Head of Clinical Development at PACT Pharma
Dr. Antoni Ribas
Professor of Medicine, Professor of Surgery, and Professor of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA)
Dr. Jeffrey Heier
Director of the Vitreoretinal Service and Director of Retina Research at OCB
Dr. Joseph Merola
Associate Professor in the Department of Dermatology and Department of Medicine, Division of Rheumatology at Harvard Medical School
Dr. Peter Kaiser
Chaney Family Endowed Chair of Ophthalmic Research and a Professor of Ophthalmology at the Cleveland Clinic
Dr. Jonathan Zung
Chief Development Officer at Evelo Biosciences
